December 3, 2022
Loading...
You are here:  Home  >  'FDA'
Latest

Sientra wins new FDA approval

By   /  Thursday, July 7th, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, Regions, Santa Barbara County, Tri-County Public Companies  /  Comments Off on Sientra wins new FDA approval

The U.S. Food and Drug Administration approved a new breast implant on July 6 made by Goleta-based Sientra. Sientra’s Low Plus Profile Projection Breast Implant will be commercially available to plastic surgeons in the United States in late July, the company said in a news release. It is for cosmetic surgery for women at least Read More →

Latest

Atara reports patient death in cancer treatment study

By   /  Tuesday, February 22nd, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on Atara reports patient death in cancer treatment study

Atara Biotherapeutics, a South San Francisco-based drug development company with major operations in Thousand Oaks, reported to the U.S. Food and Drug Administration on Feb. 18 that a patient died in one of its Phase 1 trials. The patient, who was being treated at a Memorial Sloan Kettering Cancer Center location in New York, suffered Read More →

Latest

Our View: Deja vu as 2022 begins, but with some big differences

By   /  Friday, January 7th, 2022  /  Editorials, Health Care & Life Science, Latest news, Opinion  /  Comments Off on Our View: Deja vu as 2022 begins, but with some big differences

We begin 2022 as we ended 2021, with the newest variant of the virus dominating the headlines. As the Business Times goes to press on its first edition of the year, it is back to the future, as most meetings and live events have moved to virtual. Virtual meetings are a poor substitute for in-person, Read More →

Latest

Amgen’s new asthma treatment gets FDA approval

By   /  Wednesday, December 22nd, 2021  /  Banking & Finance, East Ventura County, Health Care & Life Science, Latest news, Subscriber content, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen’s new asthma treatment gets FDA approval

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

FDA accuses Amgen of misleading advertising

By   /  Friday, July 16th, 2021  /  Banking & Finance, East Ventura County, Health Care & Life Science, Latest news, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on FDA accuses Amgen of misleading advertising

The U.S. Food and Drug Administration tagged Amgen with a letter July 7 that says the Thousand Oaks biotech firm made “misleading claims” in advertisements for its drug Neulasta, by suggesting it is more effective than biosimilar competitors. Neulasta is a prescription medication used to reduce infection risk from febrile neutropenia (a low level of Read More →

Latest

FDA gives Amgen priority review for asthma treatment

By   /  Friday, July 9th, 2021  /  Banking & Finance, East Ventura County, Health Care & Life Science, Latest news, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on FDA gives Amgen priority review for asthma treatment

Thousand Oaks-based Amgen received a priority review for tezepelumab, a treatment for asthma, from the U.S. Food and Drug Administration, the biotech giant announced July 7. According to Amgen, tezepelumab is the first and only biologic to consistently and significantly reduce asthma exacerbations in a broad population of clients in phase 2 and 3 trials. Read More →

Latest

Amgen gets FDA approval for potential billion-dollar drug

By   /  Friday, May 28th, 2021  /  Banking & Finance, East Ventura County, Health Care & Life Science, Latest news, right, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen gets FDA approval for potential billion-dollar drug

Thousand Oaks-based Amgen won approval from the U.S. Food and Drug Administration on May 28 for its latest oral drug treatment, Lumakras, potentially adding another huge market for one of the largest biotech firms in the world. According to the Wall Street Journal, Amgen will charge $17,900 a month for the drug and analyst think Read More →